Baxter halts production of blood thinner

Share this content:
Baxter International has temporarily halted production of certain heparin vials amid reports of serious adverse reactions to the widely used, injectable blood thinner. Baxter has not broadened a prior recall of heparin, however. Baxter sells about 100,000 vials of the generic prescription drug each day.

Next Article in Products